CLINICAL_TRIALS ClinicalTrials.gov record update

A Feasibility Study of SGM-101, a Fluorochrome-labeled Anti-carcinoembryonic Antigen Monoclonal Antibody for the Intraoperative Detection of Colorectal Brain Metastases.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04755920
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:32.938470+00:00
Published At: 2024-05-09T00:00:00+00:00
Record Updated At: 2024-05-09
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Rectal Neoplasms", "Rectum Cancer", "Colorectal Neoplasms", "Brain Metastases", "Brain Neoplasms", "Brain Diseases", "Brain Cancer", "Brain Tumor", "Intestinal Neoplasms", "Gastrointestinal Neoplasms", "Gastrointestinal Cancer", "Gastrointestinal Disease", "Intestinal Disease"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2024-05-09"
protocolSection.identificationModule.nctId: "NCT04755920"
protocolSection.identificationModule.officialTitle: "A Feasibility Study of SGM-101, a Fluorochrome-labeled Anti-carcinoembryonic Antigen Monoclonal Antibody for the Intraoperative Detection of Colorectal Brain Metastases."
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.